Dolby Laboratories, Inc.
DLB
$67.48
$1.973.01%
NYSE
| 09/26/2025 | 06/27/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -2.70% | -14.62% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.70% | -14.62% | |||
| Cost of Revenue | -10.19% | 22.78% | |||
| Gross Profit | -1.49% | -18.63% | |||
| SG&A Expenses | 3.64% | -0.98% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.03% | 4.22% | |||
| Operating Income | -23.97% | -57.94% | |||
| Income Before Tax | -24.94% | -53.83% | |||
| Income Tax Expenses | -188.99% | -67.98% | |||
| Earnings from Continuing Operations | 6.69% | -49.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 31.63% | -8.78% | |||
| Net Income | 7.08% | -49.81% | |||
| EBIT | -23.97% | -57.94% | |||
| EBITDA | -16.25% | -48.30% | |||
| EPS Basic | 7.39% | -49.59% | |||
| Normalized Basic EPS | -12.56% | -55.94% | |||
| EPS Diluted | 6.69% | -48.94% | |||
| Normalized Diluted EPS | -12.75% | -55.88% | |||
| Average Basic Shares Outstanding | -0.28% | -0.45% | |||
| Average Diluted Shares Outstanding | -0.06% | -0.59% | |||
| Dividend Per Share | 9.09% | 0.00% | |||
| Payout Ratio | -0.07% | 0.98% | |||